Loading...

GILD GILEAD SCIENCES INC Management Changes 8-K Filing

GLD

GLD

GILEAD SCIENCES INC

(GILD)

2024 8-K

Merger Announcement

Financial Results Announced

Management Change

Earnings Report

Patent Settlement Announced

Management Change

Financial Statements

Board Amendments

Financial Statements

Management Change

Financial Results

Management Change

Financial Results

Financial Results Announcement

Departure of Chief Medical ...

Amendment to Restated Certi...

Financial Results Announcement

Acquisition of CymaBay Ther...

Departure of Director

Merger Agreement

Financial Results Announcement

Appointment of Director

Financial Results Announcement

Indenture for Senior Notes ...

Unauthorized Presentation P...

Financial Results Announcement

Approval of Amendment and R...

Financial Results Announcement

External Links:

Gilead Sciences announced the departure of Chief Medical Officer Merdad V. Parsey, who will be succeeded by Dietmar Berger starting January 2, 2025, while Parsey will remain as a Senior Advisor until the end of Q1 2025.

AI Assistant

GILEAD SCIENCES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.